United States · Telehealth platform · Brand-name and compounded
Maximus review
Runs the compounded and brand tiers side by side — compounded from $116, Wegovy tablets from $199.99, Zepbound from $449.99 — with the trade-off stated on the page.
Overview
Maximus is one of the few services that sells both tiers and sets them out against each other rather than steering you to the cheaper one. Compounded semaglutide starts at $116 per 28-day supply and compounded tirzepatide at $198, described together as “$149.99-$249.99 per month, out of pocket” and “Prepared by licensed US compounding pharmacies”. The brand shelf runs from Foundayo tablets at $199.99 and Wegovy tablets at $249.99 up through Wegovy pens at $349.99, Zepbound at $449.99 and Mounjaro at $1,249.99, summarised as “From $499 per month” with “Insurance and savings cards may apply”.
That comparison is the useful thing here. The page states the regulatory difference in its own words — the compounded products are “Prepared by licensed US compounding pharmacies”, the brand ones “FDA-approved and manufactured by Novo Nordisk or Eli Lilly” — and contrasts custom dosing in vial-and-syringe format against “Fixed doses in pre-filled” pens. A reader can see what the extra money buys.
The service is available in every state except Alabama, Mississippi and Louisiana. HSA and FSA cards are accepted. If a prescriber declines you, the site promises “a full refund (minus the cost of the doctor consultation)” — so the consultation is chargeable, though the amount is not stated on this page. FDA issued a warning letter to Maximus Health, Inc. in June 2026, set out above.
Medications and supply
Both tiers, clearly labelled. Compounded products are “Compounded in US-based pharmacies” and “Prepared by licensed US compounding pharmacies”; the brand products are described as “FDA-approved and manufactured by Novo Nordisk or Eli Lilly”. No individual pharmacy is named and no 503A or 503B status is given, though the page does refer to a “pharmacy partner” for stock reliability.
- Compounded semaglutide
- Compounded tirzepatide
- Wegovy (semaglutide) pens and tablets
- Ozempic (semaglutide)
- Zepbound (tirzepatide)
- Mounjaro (tirzepatide)
- Foundayo (oral GLP-1 tablets)
How the service works
- Consultation
- Online, with a chargeable doctor consultation — the refund terms deduct “the cost of the doctor consultation”, though the fee itself is not published on this page.
- Eligibility
- Framed loosely: GLP-1 treatment “may be appropriate if you’re trying to lose weight, reduce appetite, improve blood sugar”. No BMI threshold published. Not available in Alabama, Mississippi or Louisiana.
- Provider involvement
- A doctor reviews and decides whether treatment is appropriate; if not approved, the medication cost is refunded. The page directs patients to contact their provider about specific side effects including possible pancreatitis and thyroid symptoms.
- Lab requirements
- Lab testing is offered as a separate product line — comprehensive panels up to 146 markers and an at-home testosterone test — rather than required for weight-loss treatment.
- Pharmacy fulfilment
- Not named. Compounded medication is “Compounded in US-based pharmacies”, with supply described as “Reliably in stock through our pharmacy partner”. No 503A or 503B designation.
- Shipping
- Free and discreet shipping, in unmarked packaging.
- Support services
- Ongoing dose adjustments are included — “Custom dosing and ongoing adjustments”.
What it costs
| Item | Published price | Notes |
|---|---|---|
| Compounded semaglutide | from $116 / 28-day supply | Custom dosing, vial and syringe |
| Compounded tirzepatide | from $198 / 28-day supply | Compounded tier stated overall as $149.99–$249.99 per month |
| Foundayo tablets | from $199.99 / month | Brand-name, FDA-approved oral GLP-1 |
| Wegovy tablets | from $249.99 / month | Brand-name |
| Wegovy pens | from $349.99 / month | Brand-name |
| Zepbound | from $449.99 / month | Brand-name |
| Mounjaro | from $1,249.99 / month | Brand-name |
| Doctor consultation | Not published | Confirmed to exist because the refund policy deducts it |
- Membership fee
- None published.
- Medication fee
- Bundled into the per-supply price.
- Insurance
- Not accepted for the compounded tier — “No insurance required” and “out of pocket”. For the brand tier, “Insurance and savings cards may apply”.
- HSA / FSA
- “Maximus accepts both HSA and FSA cards for weight loss treatment.”
- Cancellation
- Not stated in the sources we checked.
- Refunds
- If a prescriber does not approve treatment, “you’ll receive a full refund (minus the cost of the doctor consultation)”.
Pros
- Sells both tiers and states the regulatory difference between them on the page, which lets a reader make the trade-off rather than be steered.
- Carries the newer oral options, including Wegovy tablets and Foundayo, at prices well below the injectable brand pens.
- HSA and FSA accepted, confirmed explicitly.
- Full refund of medication cost if the prescriber declines.
- Lab testing available, though not bundled.
Cons
- An FDA warning letter to Maximus Health, Inc. in June 2026.
- The consultation fee is chargeable but never published — you learn it exists from the refund policy.
- No pharmacy named and no 503A or 503B status.
- No cancellation terms published anywhere we could find.
- Not available in Alabama, Mississippi or Louisiana.
Who it may suit
Someone weighing compounded against brand who wants both prices from one place. The oral brand options at $199.99–$249.99 are the interesting part of this listing — materially cheaper than brand pens and not compounded. Get the consultation fee confirmed before starting.
Limitations
- We could not retrieve the FDA warning letter itself, only its existence, reference and date.
- The consultation fee is not published, so the true entry cost cannot be calculated.
- No cancellation policy is published, so it could not be checked.
- Prices are “starting at” figures and may rise with dose on the compounded tier despite the stated range.
Questions
How much is Maximus?
Compounded semaglutide starts at $116 per 28-day supply and tirzepatide at $198, with the compounded tier stated as $149.99–$249.99 a month overall. Brand-name runs from Foundayo tablets at $199.99 and Wegovy tablets at $249.99 up to Zepbound at $449.99 and Mounjaro at $1,249.99. A doctor consultation is charged separately and its price is not published.
Does Maximus sell brand-name or compounded?
Both, and it labels them. Compounded products are “Prepared by licensed US compounding pharmacies”; brand products are “FDA-approved and manufactured by Novo Nordisk or Eli Lilly”. Very few services in this market present the two side by side with the distinction stated.
Can I use HSA or FSA?
Yes — the site states plainly that “Maximus accepts both HSA and FSA cards for weight loss treatment”. Insurance is not accepted for compounded medication, but savings cards and insurance may apply to the brand tier.
What if I am not approved?
You get “a full refund (minus the cost of the doctor consultation)”. That is the sentence which confirms a consultation fee exists; the amount is not stated on the weight-loss page.
Where is Maximus available?
Nationwide except Alabama, Mississippi and Louisiana.
Sources
Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.